Delivery Order SPE2DB20D3303-SPE2DB24FA0FU
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,632.54. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order and is priced on a firm fixed price basis. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $2,176.72. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $7,136.28. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 21, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract, valued at $1,578.00, was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed-price delivery order structure and an ultimate completion date of September 23, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, valued at $17,221.23, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., doing business as Amerisourcebergen. This is a delivery order contract with a firm fixed price, and the ultimate completion date is set for April 25, 2023....
This federal contract award is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,114.62. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price, and there was no set-aside designation used. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, valued at $1,052.00. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed price agreement with an ultimate completion date of November 6, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA), which is a defense agency. The contract, valued at $2,698.64, was awarded to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award is for the delivery of 4566280894 units of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract, valued at $1,052.00, was awarded to the prime contractor Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a firm fixed price pricing type and an ultimate completion date of October 31, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a delivery order with a firm fixed price of $11,065.60 and an ultimate completion date of May 24, 2024. It is not...